---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-051511"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T05:07:23.672732+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical: Dr. Haring-Smith resigns from board; Michael Crowe appointed

## Summary
- Dr. Whitney Haring-Smith resigned effective June 6, 2024; no disagreement.
- Board appointed Michael Crowe on June 7, 2024 to fill vacancy.
- Crowe receives $40k annual cash and 25,000-share option award vesting over 4 years.
- Crowe is SVP Operations at Bioventus, former VP Operations at Abbott Vascular.
- Envoy expects to begin pivotal clinical study for Acclaim CI later in 2024.

## SEC filing metadata
- accession: 0001213900-24-051511
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390024051511/0001213900-24-051511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390024051511/ea0207623-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-051511
- JSON: https://secwatch.observer/filing/0001213900-24-051511.json
- Plain text: https://secwatch.observer/filing/0001213900-24-051511.txt

## Key facts
- Executive change
  Michael Crowe was appointed as Director at Envoy Medical, Inc..
  - Action: appointed
  - Role: Director
  source text: On June 7, 2024, the Board appointed Michael Crowe to fill the vacancy created by Dr. Haring-Smith’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390024051511/0001213900-24-051511-index.htm
- Executive change
  Whitney Haring-Smith resigned as Director at Envoy Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: On June 6, 2024, Dr. Whitney Haring-Smith, notified the Company of his decision to resign from the board of directors of the Company (the “Board”) effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390024051511/0001213900-24-051511-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.